FMR »

Alnylam Pharmaceuticals shares owned by FMR

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by FMR from 13F filings

Historical chart of FMR investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by FMR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by FMR

Quarter filed Position value Share count Share price at filing
2010-12-31 $57M 5.8M 9.86

More positions owned by FMR

NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl A (BRK.A)
UnitedHealth (UNH)
Exxon Mobil Corporation Put Option (XOM)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
Netflix (NFLX)
General Electric Com New (GE)
salesforce (CRM)

View all positions for FMR

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
Vanguard Group
BlackRock
BlackRock
Capital Research Global Investors
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies
Groupama Asset Managment

View all funds holding Alnylam Pharmaceuticals